Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jun;39(6):688–691. doi: 10.1111/j.1365-2125.1995.tb05730.x

Does luminol chemiluminescence detect free radical scavengers?

M Clapperton 1, J McMurray 1, A C Fisher 1, H J Dargie 1
PMCID: PMC1365084  PMID: 7654490

Abstract

Thiol compounds have been reported to abolish hypoxanthine/xanthine oxidase induced luminol chemiluminescence and this effect has been attributed to scavenging of superoxide (O2-)/(H2O2) produced from hypoxanthine/xanthine oxidase. Yet other workers have reported that thiol compounds have shown little, if any, reactivity towards O2-/H2O2. The aim of this study was to examine the discrepancy between these two sets of findings further. Captopril (a thiol angiotensin-converting enzyme (ACE) inhibitor) and MPG (a simple thiol) were observed to abolish hypoxanthine/xanthine oxidase induced chemiluminescence. The reactivity of captopril and MPG towards O2-/H2O2 was then determined by measurement of thiol oxidation in captopril and MPG after their incubation with hypoxanthine/xanthine oxidase. Incubation (at 10 min, 37 degrees C) with 4 mM hypoxanthine/0.03 u ml-1 xanthine oxidase resulted in 7% and 20% thiol oxidation in captopril and MPG (at 1 mM) respectively. Captopril and MPG, therefore, appeared to be ineffective scavengers of oxidants produced by hypoxanthine/xanthine oxidase. Captopril and MPG also did not affect urate production or oxygen consumption by xanthine oxidase which indicated that captopril and MPG quench luminol chemiluminescence by a mechanism that excludes the inhibition of xanthine oxidase. Hypoxanthine/xanthine oxidase induced luminol chemiluminescence may, therefore, be an unsuitable method for measuring free radical scavenging activity by drugs.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aruoma O. I., Akanmu D., Cecchini R., Halliwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chem Biol Interact. 1991;77(3):303–314. doi: 10.1016/0009-2797(91)90039-a. [DOI] [PubMed] [Google Scholar]
  2. Bagchi D., Prasad R., Das D. K. Direct scavenging of free radicals by captopril, an angiotensin converting enzyme inhibitor. Biochem Biophys Res Commun. 1989 Jan 16;158(1):52–57. doi: 10.1016/s0006-291x(89)80175-5. [DOI] [PubMed] [Google Scholar]
  3. Chopra M., Beswick H., Clapperton M., Dargie H. J., Smith W. E., McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol. 1992 Mar;19(3):330–340. doi: 10.1097/00005344-199203000-00005. [DOI] [PubMed] [Google Scholar]
  4. ELLMAN G. L. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. doi: 10.1016/0003-9861(59)90090-6. [DOI] [PubMed] [Google Scholar]
  5. Halliwell B. How to characterize a biological antioxidant. Free Radic Res Commun. 1990;9(1):1–32. doi: 10.3109/10715769009148569. [DOI] [PubMed] [Google Scholar]
  6. Hodgson E. K., Fridovich I. The role of O2- in the chemiluminescence of luminol. Photochem Photobiol. 1973 Dec;18(6):451–455. doi: 10.1111/j.1751-1097.1973.tb06449.x. [DOI] [PubMed] [Google Scholar]
  7. McCord J. M., Day E. D., Jr Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex. FEBS Lett. 1978 Feb 1;86(1):139–142. doi: 10.1016/0014-5793(78)80116-1. [DOI] [PubMed] [Google Scholar]
  8. Radi R. A., Rubbo H., Prodanov E. Comparison of the effects of superoxide dismutase and cytochrome c on luminol chemiluminescence produced by xanthine oxidase-catalyzed reactions. Biochim Biophys Acta. 1989 Jan 19;994(1):89–93. doi: 10.1016/0167-4838(89)90066-6. [DOI] [PubMed] [Google Scholar]
  9. Radi R., Rubbo H., Thomson L., Prodanov E. Luminol chemiluminescence using xanthine and hypoxanthine as xanthine oxidase substrates. Free Radic Biol Med. 1990;8(2):121–126. doi: 10.1016/0891-5849(90)90084-v. [DOI] [PubMed] [Google Scholar]
  10. Samuni A., Krishna C. M., Cook J., Black C. D., Russo A. On radical production by PMA-stimulated neutrophils as monitored by luminol-amplified chemiluminescence. Free Radic Biol Med. 1991;10(5):305–313. doi: 10.1016/0891-5849(91)90037-4. [DOI] [PubMed] [Google Scholar]
  11. Vilim V., Wilhelm J. What do we measure by a luminol-dependent chemiluminescence of phagocytes? Free Radic Biol Med. 1989;6(6):623–629. doi: 10.1016/0891-5849(89)90070-1. [DOI] [PubMed] [Google Scholar]
  12. Wefers H., Sies H. Oxidation of glutathione by the superoxide radical to the disulfide and the sulfonate yielding singlet oxygen. Eur J Biochem. 1983 Dec 1;137(1-2):29–36. doi: 10.1111/j.1432-1033.1983.tb07791.x. [DOI] [PubMed] [Google Scholar]
  13. Wilhelm J., Vilím V. Variables in xanthine oxidase-initiated luminol chemiluminescence: implications for chemiluminescence measurements in biological systems. Anal Biochem. 1986 Oct;158(1):201–210. doi: 10.1016/0003-2697(86)90610-x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES